Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-25-080232

Options or other derivatives

  • Director acquired 22,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Verjee Rehan Director 2025-05-29 Grant or award · Stock Option (Right to Buy) +22,200 22,200 D
Loading xslF345X05/ownership.xml…